Record NNP B-NP O
date NN I-NP O
: : O O
2128-02-26 CD O B-DATE
Lynchburg NNP B-NP B-HOSPITAL
City NNP I-NP I-HOSPITAL
Health NNP I-NP I-HOSPITAL
Department NNP I-NP I-HOSPITAL
7609 CD B-NP B-STREET
New NNP I-NP I-STREET
Hampshire NNP I-NP I-STREET
Avenue NNP I-NP I-STREET
Kigali NNP B-NP B-CITY
, , O O
NJ NNP B-NP B-STATE
47798 CD I-NP B-ZIP
497-045-1949 CD O B-PHONE
HOLCOMB NNP B-NP I-PATIENT
, , O I-PATIENT
DENNIS . O I-PATIENT
83312060 CD O B-MEDICALRECORD
02/26/2128 CD O B-DATE
DATE NNP B-NP O
OF IN B-PP O
BIRTH NNP B-NP O
: : O O
12/14/67 CD O B-DATE
CHIEF JJ B-NP O
COMPLAINT NN I-NP O
: : O O
He PRP B-NP O
presents VBZ B-VP O
today NN B-NP O
for IN B-PP O
his PRP$ B-NP O
annual JJ I-NP O
history NN I-NP O
and CC O O
physical JJ B-ADVP O
after IN B-PP O
an DT B-NP O
absence NN I-NP O
to TO B-PP O
this DT B-NP O
office NN I-NP O
for IN B-PP O
the DT B-NP O
past JJ I-NP O
2 CD I-NP O
years NNS I-NP O
. . O O
PAST NN B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Includes VBZ B-VP O
poorly RB I-VP O
controlled VBN I-VP O
type NN B-NP O
2 CD I-NP O
diabetes NN I-NP O
, , O O
currently RB B-ADVP O
on IN B-PP O
insulin NN B-NP O
for IN B-PP O
the DT B-NP O
past JJ I-NP O
33 CD I-NP O
years NNS I-NP O
, , O O
history NN B-NP O
of IN B-PP O
left JJ B-NP O
foot NN I-NP O
infection NN I-NP O
, , O O
erectile IN B-PP O
dysfunction NN B-NP O
, , O O
onychomycosis NN B-NP O
of IN B-PP O
toenails NNS B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
CAD NNP B-NP O
, , O O
inferior JJ B-NP O
myocardial JJ I-NP O
infarction NN I-NP O
complicated VBN B-VP O
by IN B-PP O
ventricular JJ B-NP O
tachycardia NN I-NP O
, , O O
obesity NN B-NP O
, , O O
diabetic JJ B-NP O
retinopathy NN I-NP O
, , O O
ischemic JJ B-NP O
cardiomyopathy NN I-NP O
and CC O O
low JJ B-NP O
testosterone NN I-NP O
. . O O
PAST NNP B-NP O
SURGICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Include VB B-VP O
cardiac JJ B-NP O
catheterization NN I-NP O
, , O O
coronary JJ B-NP O
stenting NN I-NP O
and CC O O
implantable JJ B-NP O
cardiac NN I-NP O
defibrillator NN I-NP O
. . O O
DRUG NNP B-NP O
ALLERGIES NNS I-NP O
: : O O
He PRP B-NP O
has VBZ B-VP O
no RB I-VP O
known VBN I-VP O
drug NN B-NP O
allergies NNS I-NP O
. . O O
MEDICATIONS NNS B-NP O
: : O O
Include NNP B-NP O
atenolol VBD B-VP O
100 CD B-NP O
mg NN I-NP O
in IN B-PP O
the DT B-NP O
morning NN I-NP O
and CC O O
50 CD B-NP O
mg NN I-NP O
in IN B-PP O
the DT B-NP O
evening NN I-NP O
, , O O
aspirin VBD B-VP O
81 CD B-NP O
mg NN I-NP O
2 CD B-NP O
tablets NNS I-NP O
daily RB B-ADVP O
, , O O
folic JJ B-NP O
acid NN I-NP O
1 CD B-NP O
mg NN I-NP O
daily RB B-ADVP O
, , O O
furosemide RB B-NP O
40 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
, , I-NP O
NPH NNP I-NP O
40-42 CD I-NP O
units NNS I-NP O
once RB B-ADVP O
daily RB I-ADVP O
, , O O
regular JJ B-NP O
insulin NN I-NP O
for IN B-PP O
sliding VBG B-VP O
scale NN B-NP O
, , O O
lisinopril JJ B-NP O
5 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
, , I-NP O
multivitamin NN I-NP O
once RB B-ADVP O
daily RB I-ADVP O
, , O O
simvastatin RB B-ADVP O
20 CD B-NP O
mg NN I-NP O
at IN B-PP O
bedtime NN B-NP O
, , O O
B12 NNP B-NP O
250 CD I-NP O
mcg NN I-NP O
by IN B-PP O
mouth NN B-NP O
daily JJ B-ADVP O
, , O O
vitamin NN B-NP O
C NNP I-NP O
1000 CD I-NP O
units NNS I-NP O
daily RB B-ADVP O
, , O O
and CC O O
over-the-counter JJ B-NP O
cholesterol-lowering JJ I-NP O
medication NN I-NP O
. . O O
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Father NNP B-NP O
and CC I-NP O
brother NN I-NP O
died VBD B-VP O
of IN B-PP O
cerebral JJ B-NP O
aneurysms NNS I-NP O
, , O O
both DT B-NP O
were VBD B-VP O
hypertensive JJ B-ADJP O
and CC O O
smokers NNS B-NP O
, , O O
there EX B-NP O
is VBZ B-VP O
also RB B-ADVP O
history NN B-NP O
of IN B-PP O
cardiac JJ B-NP O
disease NN I-NP O
in IN B-PP O
his PRP$ B-NP O
grandparents NNS I-NP O
. . O O
SOCIAL JJ B-NP O
HISTORY NN I-NP O
: : O O
Single NNP B-NP O
, , O O
works VBZ B-VP O
for IN B-PP O
the DT B-NP O
Alaska NNP I-NP B-ORGANIZATION
Air NNP I-NP I-ORGANIZATION
Group NNP I-NP I-ORGANIZATION
in IN B-PP O
Juneau NNP B-NP B-CITY
, , O O
drinks NNS B-NP O
1-2 JJ B-NP O
beers NNS I-NP O
a DT B-NP O
year NN I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
a DT B-NP O
nonsmoker NN I-NP O
, , O O
does VBZ B-VP O
not RB I-VP O
use VB I-VP O
IV NNP B-NP O
drugs NNS I-NP O
, , O O
he PRP B-NP O
is VBZ B-VP O
responsible JJ B-ADJP O
to TO B-VP O
take VB I-VP O
care NN B-NP O
of IN B-PP O
several JJ B-NP O
sick JJ I-NP O
individuals NNS I-NP O
that WDT B-NP O
are VBP B-VP O
very RB B-ADVP O
close RB I-ADVP O
to TO B-PP O
his PRP$ B-NP O
life NN I-NP O
, , O O
therefore RB B-ADVP O
he PRP B-NP O
claims VBZ B-VP O
he PRP B-NP O
cannot MD B-VP O
attention NN B-NP O
to TO B-PP O
his PRP$ B-NP O
own JJ I-NP O
personal JJ I-NP O
health NN I-NP O
because IN B-PP O
of IN I-PP O
caring VBG B-VP O
for IN B-PP O
others NNS B-NP O
. . O O
HISTORY NN B-NP O
OF IN B-PP O
PRESENT JJ B-NP O
ILLNESS NNS I-NP O
: : O O
The DT B-NP O
patient NN I-NP O
presents VBZ B-VP O
today NN B-NP O
for IN B-PP O
annual JJ B-NP O
physical NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
states NNS B-VP O
he PRP B-NP O
has VBZ B-VP O
become VBN I-VP O
enlightened VBN I-VP O
recently RB B-ADVP O
that IN B-PP O
when WRB B-ADVP O
he PRP B-NP O
goes VBZ B-VP O
to TO B-PP O
Tim NNP B-NP B-ORGANIZATION
Horton NNP I-NP I-ORGANIZATION
's POS B-NP I-ORGANIZATION
, , O O
they PRP B-NP O
pretreated VBD B-VP O
his PRP$ B-NP O
coffee NN I-NP O
with IN B-PP O
sugar NN B-NP O
as IN B-PP O
a DT B-NP O
role NN I-NP O
and CC O O
he PRP B-NP O
thinks VBZ B-VP O
that DT B-NP O
is VBZ B-VP O
the DT B-NP O
reason NN I-NP O
for IN B-PP O
his PRP$ B-NP O
diabetic NN I-NP O
, , O O
lack NN B-NP O
of IN B-PP O
control NN B-NP O
over IN B-PP O
the DT B-NP O
years NNS I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
eliminating VBG I-VP O
concentrated JJ B-NP O
sweets NNS I-NP O
in IN B-PP O
his PRP$ B-NP O
diet NN I-NP O
. . O O
After IN B-PP O
a DT B-NP O
while NN I-NP O
, , O O
his PRP$ B-NP O
blood NN I-NP O
sugars NNS I-NP O
have VBP B-VP O
gotten VBN I-VP O
much JJ B-ADVP O
better RB B-ADVP O
by IN B-PP O
his PRP$ B-NP O
report NN I-NP O
. . O O
He PRP B-NP O
recently RB B-ADVP O
had VBD B-VP O
an DT B-NP O
eye NN I-NP O
examination NN I-NP O
showing VBG B-VP O
stable JJ B-NP O
background NN I-NP O
retinopathy NN I-NP O
without IN B-PP O
any DT B-NP O
recent JJ I-NP O
changes NNS I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
had VBD I-VP O
no DT B-NP O
active JJ I-NP O
podiatry NN I-NP O
issues NNS I-NP O
over IN B-PP O
the DT B-NP O
past JJ I-NP O
2 CD I-NP O
months NNS I-NP O
has VBZ B-VP O
had VBN I-VP O
no DT B-NP O
recent JJ I-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
shortness NN B-NP O
of IN B-PP O
breath NN B-NP O
or CC O O
PND. NNP B-NP O
He PRP B-NP O
sees VBZ B-VP O
Dr. NNP B-NP O
Isaac NNP I-NP B-DOCTOR
Ulibarri NNP I-NP I-DOCTOR
for IN B-PP O
a DT B-NP O
cardiomyopathy NN I-NP O
standpoint NN I-NP O
. . B-VP O
With IN B-PP O
his PRP$ B-NP O
AICD NNP I-NP O
everything NN I-NP O
seems VBZ B-VP O
to TO I-VP O
be VB I-VP O
working VBG I-VP O
fine JJ B-ADJP O
according VBG B-PP O
to TO B-PP O
him PRP B-NP O
when WRB B-ADVP O
they PRP B-NP O
interrogate VBP B-VP O
his PRP$ B-NP O
device NN I-NP O
. . O O
He PRP B-NP O
reports VBZ B-VP O
no DT B-NP O
fever NN I-NP O
, , O O
shakes VBZ B-VP O
, , O O
chills NNS B-NP O
, , O O
nausea NN B-NP O
, , I-NP O
vomiting VBG I-NP O
or CC I-NP O
diarrhea NN I-NP O
. . O O
Again RB B-ADVP O
, , O O
he PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
no DT B-NP O
recent JJ I-NP O
chest NN I-NP O
pain NN I-NP O
, , O O
PND NNP B-NP O
, , O O
or CC O O
orthopnea NN B-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
no DT B-NP O
dysphagia NN I-NP O
, , O O
odynophagia NNP B-NP O
, , O O
melena NN B-NP O
, , I-NP O
hematemesis NN I-NP O
, , I-NP O
hematochezia NN I-NP O
, , I-NP O
dysuria NN I-NP O
, , I-NP O
hematuria NN I-NP O
or CC I-NP O
polyuria NN I-NP O
. . O O
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
: : O O
Blood NN B-NP O
pressure NN I-NP O
is VBZ B-VP O
126/70 CD B-NP O
in IN B-PP O
the DT B-NP O
right JJ I-NP O
arm NN I-NP O
, , O O
temperature NN B-NP O
95.6 CD I-NP O
, , O O
pulse NN B-NP O
78 CD I-NP O
, , O O
respirations NNS B-NP O
are VBP B-VP O
16 CD B-NP O
, , O O
O2 NNP B-NP O
sat VBD B-VP O
97 CD B-NP O
% NN I-NP O
on IN B-PP O
room NN B-NP O
air NN I-NP O
. . O O
He PRP B-NP O
is VBZ B-VP O
67 CD B-NP O
inches NNS I-NP O
tall JJ B-ADJP O
, , O O
222 CD B-NP O
pounds NNS I-NP O
. . O O
BMI NNP O O
34.8. VBD B-VP O
HEENT NNP B-NP O
: : O O
Normocephalic NNP B-NP O
, , I-NP O
atraumatic JJ I-NP O
, , I-NP O
pupils NNS I-NP O
are VBP B-VP O
equally RB B-ADJP O
round JJ I-ADJP O
and CC O O
reactive JJ B-ADJP O
to TO B-PP O
light NN B-NP O
and CC I-NP O
accommodation NN I-NP O
. . O O
Extraocular JJ B-NP O
movements NNS I-NP O
were VBD B-VP O
intact JJ B-ADJP O
. . O O
He PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
minimal JJ B-NP O
wax NN I-NP O
buildup NN I-NP O
bilaterally RB B-ADVP O
. . O O
TMs NNS B-NP O
were VBD B-VP O
intact JJ B-ADJP O
. . O O
Oropharynx NNP B-NP O
was VBD B-VP O
clear JJ B-ADJP O
without IN B-PP O
erythema NN B-NP O
or CC I-NP O
exudate NN I-NP O
. . O O
Sinuses NNPS B-NP O
were VBD B-VP O
nontender JJ B-ADJP O
. . O O
Nostrils NNS B-NP O
were VBD B-VP O
patent NN B-NP O
. . O O
Neck NN B-NP O
is VBZ B-VP O
supple NN B-NP O
Supple NN I-NP O
without IN B-PP O
JVD NNP B-NP O
, , I-NP O
lymphadenopathy NN I-NP O
or CC I-NP O
thyromegaly RB I-NP O
. . O O
Lungs NNS B-NP O
are VBP B-VP O
clear JJ B-ADJP O
to TO B-PP O
auscultation NN B-NP O
bilaterally RB B-ADVP O
without IN B-PP O
wheezes NNS B-NP O
, , O O
rubs NNS B-NP O
or CC O O
rhonchi NNP B-NP O
. . I-NP O
Heart NNP I-NP O
regular JJ I-NP O
rate NN I-NP O
and CC I-NP O
rhythm NN I-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NNS I-NP O
, , I-NP O
rubs NNS I-NP O
or CC I-NP O
gallops NNS I-NP O
were VBD B-VP O
appreciated VBN I-VP O
. . O O
Abdomen NNP B-NP O
is VBZ B-VP O
soft JJ B-ADJP O
, , O O
nontender JJ B-NP O
, , I-NP O
nondistended JJ I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
a DT B-NP O
small JJ I-NP O
umbilical JJ I-NP O
hernia NN I-NP O
that WDT B-NP O
is VBZ B-VP O
not RB I-VP O
protruding VBG I-VP O
and CC I-VP O
bowel NN B-NP O
sounds NNS I-NP O
are VBP B-VP O
active JJ B-ADJP O
. . O O
He PRP B-NP O
has VBZ B-VP O
no DT B-NP O
organomegaly NN I-NP O
and CC O O
there EX B-NP O
is VBZ B-VP O
no DT B-NP O
CVA NNP I-NP O
tenderness NN I-NP O
. . O O
Extremities NNS B-NP O
are VBP B-VP O
without IN B-PP O
clubbing VBG B-NP O
, , I-NP O
cyanosis NN I-NP O
or CC I-NP O
edema NN I-NP O
. . O O
He PRP B-NP O
does VBZ B-VP O
have VB I-VP O
significant JJ B-NP O
thickening NN I-NP O
and CC I-NP O
brittleness NN I-NP O
of IN B-PP O
the DT B-NP O
toenails NNS I-NP O
of IN B-PP O
both DT B-NP O
feet NNS I-NP O
consistent JJ B-ADJP O
with IN B-PP O
onychomycosis NN B-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
no DT B-NP O
open JJ I-NP O
sores NNS I-NP O
of IN B-PP O
the DT B-NP O
feet NNS I-NP O
. . O O
Neurologically RB B-ADVP O
, , O O
he PRP B-NP O
is VBZ B-VP O
alert JJ B-ADJP O
and CC I-ADJP O
oriented JJ I-ADJP O
x3 NNS B-NP O
and CC O O
grossly RB B-ADJP O
nonfocal JJ I-ADJP O
with IN B-PP O
intact JJ B-NP O
distal JJ I-NP O
sensation NN I-NP O
to TO B-PP O
light JJ B-NP O
touch NN I-NP O
in IN B-PP O
both DT B-NP O
feet NNS I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
no DT B-NP O
generalized JJ I-NP O
lymphadenopathy NN I-NP O
and CC O O
his PRP$ B-NP O
joint JJ I-NP O
examination NN I-NP O
shows VBZ B-VP O
no DT B-NP O
effusions NNS I-NP O
or CC I-NP O
erythema NN I-NP O
. . O O
ASSESSMENT NNP B-NP O
AND CC I-NP O
PLAN NNP I-NP O
: : O O
1 LS O O
. . B-NP O
Annual NNP I-NP O
physical JJ I-NP O
, , I-NP O
preventative JJ I-NP O
maintenance NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
had VBD B-VP O
a DT B-NP O
colonoscopy NN I-NP O
in IN B-PP O
2125 CD B-NP B-DATE
and CC O O
was VBD B-VP O
told VBN I-VP O
to TO I-VP O
come VB I-VP O
back RB B-ADVP O
in IN B-PP O
2130 CD B-NP B-DATE
because IN B-PP O
of IN I-PP O
benign JJ B-NP O
polyps NNS I-NP O
. . O O
I PRP B-NP O
did VBD B-VP O
recommend VB I-VP O
guaiac NN B-NP O
stool NN I-NP O
cards NNS I-NP O
today NN I-NP O
for IN B-PP O
home NN B-NP O
testing NN I-NP O
purposes NNS I-NP O
. . O O
Immunizations NNS B-NP O
are VBP B-VP O
up-to-date JJ B-ADJP O
. . O O
He PRP B-NP O
did VBD B-VP O
receive VB I-VP O
an DT B-NP O
H1N1 NNP I-NP O
and CC O O
a DT B-NP O
seasonal JJ I-NP O
flu NN I-NP O
vaccine NN I-NP O
through IN B-PP O
his PRP$ B-NP O
employer NN I-NP O
and CC B-PP O
for IN B-PP O
private JJ B-NP O
pharmacies NNS I-NP O
. . O O
His PRP$ B-NP O
Pneumovax NN I-NP O
is VBZ B-VP O
due JJ B-ADJP O
to TO B-VP O
be VB I-VP O
a DT B-NP O
booster NN I-NP O
in IN B-PP O
2 CD B-NP O
years NNS I-NP O
' POS B-NP O
time NN I-NP O
. . O O
We PRP B-NP O
are VBP B-VP O
recommending VBG I-VP O
a DT B-NP O
PSA NNP I-NP O
and CC O O
a DT B-NP O
DRE NN I-NP O
annually RB B-VP O
starting VBG I-VP O
today NN B-NP O
. . O O
Labs NNS B-NP O
were VBD B-VP O
also RB I-VP O
drawn VBN I-VP O
in IN B-PP O
the DT B-NP O
office NN I-NP O
for IN B-PP O
CBC NNP B-NP O
, , O O
CMP NNP B-NP O
, , O O
and CC O O
lipid JJ B-NP O
profile NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
is VBZ B-VP O
declining VBG I-VP O
Zostavax RB B-ADVP O
at IN B-PP O
this DT B-NP O
time NN I-NP O
. . O O
We PRP B-NP O
will MD B-VP O
recommend VB I-VP O
a DT B-NP O
followup NN I-NP O
in IN B-PP O
1 CD B-NP O
year NN I-NP O
for IN B-PP O
an DT B-NP O
annual JJ I-NP O
physical NN I-NP O
. . O O
2. DT B-NP O
Poorly NNP I-NP O
controlled VBD B-VP O
type NN B-NP O
2 CD I-NP O
diabetes NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
has VBZ B-VP O
now RB I-VP O
eliminated VBN I-VP O
concentrated VBN I-VP O
sweets NNS B-NP O
from IN B-PP O
his PRP$ B-NP O
diet NN I-NP O
, , O O
although IN B-SBAR O
I PRP B-NP O
do VBP B-VP O
suspect VB I-VP O
dietary NN B-NP O
noncompliance NN I-NP O
beyond IN B-PP O
table NN B-NP O
sugar NN I-NP O
. . O O
Recommend VB B-VP O
checking VBG I-VP O
a DT B-NP O
hemoglobin NN I-NP O
A1c IN B-PP O
today NN B-NP O
, , O O
urine NN B-NP O
for IN B-PP O
microalbumin NN B-NP O
, , O O
lipid JJ B-NP O
panel NN I-NP O
and CC O O
creatinine VB B-VP O
as RB B-ADVP O
well RB I-ADVP O
as IN B-PP O
a DT B-NP O
BUN NNP I-NP O
and CC O O
a DT B-NP O
GFR. NNP I-NP O
I PRP B-NP O
would MD B-VP O
recommend VB I-VP O
continuing VBG I-VP O
his PRP$ B-NP O
insulin NN I-NP O
NPH RB B-ADVP O
42 CD B-NP O
units NNS I-NP O
daily RB B-ADVP O
, , O O
but CC O O
we PRP B-NP O
may MD B-VP O
need VB I-VP O
to TO I-VP O
recommend VB I-VP O
an DT B-NP O
endocrine NN I-NP O
consult VB B-VP O
if IN B-PP O
his PRP$ B-NP O
A1c JJ I-NP O
remains NNS I-NP O
elevated VBD B-VP O
despite IN B-PP O
dietary JJ B-NP O
improvement NN I-NP O
. . O O
We PRP B-NP O
did VBD B-VP O
recommend VB I-VP O
aggressive JJ B-NP O
weight NN I-NP O
loss NN I-NP O
and CC I-NP O
exercise NN I-NP O
as IN B-PP O
this DT B-NP O
is VBZ B-VP O
a DT B-NP O
major JJ I-NP O
impediment NN I-NP O
to TO B-PP O
his PRP$ B-NP O
glucose NN I-NP O
control NN I-NP O
. . O O
I PRP B-NP O
would MD B-VP O
recommend VB I-VP O
follow VB I-VP O
up RP B-PRT O
in IN B-NP O
3 CD I-NP O
to TO I-NP O
4 CD I-NP O
months NNS I-NP O
. . O O
3. CD B-NP O
Obesity NN I-NP O
. . O O
We PRP B-NP O
will MD B-VP O
check VB I-VP O
a DT B-NP O
TSH NNP I-NP O
, , I-NP O
lipid JJ I-NP O
panel NN I-NP O
and CC I-NP O
glucose NN I-NP O
to TO B-VP O
ensure VB I-VP O
that IN B-SBAR O
he PRP B-NP O
is VBZ B-VP O
in IN B-PP O
good JJ B-NP O
metabolic JJ I-NP O
balance NN I-NP O
. . O O
I PRP B-NP O
do VBP B-VP O
suspect VB I-VP O
continued VBN I-VP O
poorly RB B-NP O
controlled VBN I-NP O
diabetes NN I-NP O
given VBN B-VP O
his PRP$ B-NP O
past JJ I-NP O
history NN I-NP O
. . O O
4 CD B-LST O
. . O O
CAD NN B-VP O
with IN B-PP O
history NN B-NP O
of IN B-PP O
DVT. NNP B-NP O
He PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
an DT B-NP O
ICD NNP I-NP O
interrogated VBD B-VP O
recently RB B-ADVP O
. . O O
We PRP B-NP O
will MD B-VP O
check VB I-VP O
a DT B-NP O
lipid JJ I-NP O
panel NN I-NP O
today NN B-NP O
. . O O
We PRP B-NP O
would MD B-VP O
like VB I-VP O
to TO I-VP O
strive VB I-VP O
for IN B-PP O
an DT B-NP O
LDL NNP I-NP O
less JJR I-NP O
than IN B-PP O
70 CD B-NP O
given VBN B-VP O
his PRP$ B-NP O
high JJ I-NP O
risk NN I-NP O
status NN I-NP O
, , O O
I PRP B-NP O
would MD B-VP O
recommend VB I-VP O
changing VBG I-VP O
his PRP$ B-NP O
steroid NN I-NP O
to TO B-PP O
a DT B-NP O
higher JJR I-NP O
dose NN I-NP O
if IN B-SBAR O
required VBN B-VP O
at IN B-PP O
that DT B-NP O
point NN I-NP O
. . O O
Robert NNP B-NP B-DOCTOR
Lincoln NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
eScription NN B-NP O
document NN I-NP O
: : O O
0-37751462 CD B-NP B-IDNUM
JSSten NNP I-NP O
Tel NNP I-NP O
DD NNP B-NP O
: : O O
02/26/28 CD O B-DATE
DT NNP B-NP O
: : O O
02/26/28 CD O B-DATE
DV NNP B-NP O
: : O O
02/26/28 CD O B-DATE
